Page last updated: 2024-08-23

paroxetine and risperidone

paroxetine has been researched along with risperidone in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (15.52)	18.2507
2000's	30 (51.72)	29.6817
2010's	18 (31.03)	24.3611
2020's	1 (1.72)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ	1
Dalvie, D; Loi, CM; Smith, DA	1
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
García-Rodríguez, JA; Muñoz-Bellido, JL; Muñoz-Criado, S	1
Sitarz, WE	1
Green, AI; Patel, JK; Salzman, C; Tsuang, MT	1
O'Connor, M; Silver, H	1
Friedman, JH	1
Agid, O; Lerer, B	1
Nelson, JC; Ostroff, RB	1
Draper, B; Meares, S	1
Bottlender, R; Möller, HJ	1
Saria, A; Schatz, DS	1
Hamilton, S; Malone, K	1
Baldessarini, RJ; Tarazi, FI; Zhang, K	1
Hansen, L; Wilkinson, DG	1
Ancione, M; Avenoso, A; Facciolà, G; Madia, A; Scordo, MG; Spina, E	1
Gillman, PK	1
Hubrich-Ungureanu, P; Knopf, U; Thome, J	1
Ismail, M; Lyster, G	1
Ohmori, T; Sumitani, S	1
Shelton, RC; Stahl, SM	1
Tsai, JH; Yang, P	1
Girardi, P; Kotzalidis, GD; Lazanio, S; Manfredi, G; Ruberto, A; Tatarelli, R	1
Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Yasui-Furukori, N	1
Goto, M; Kaji, K; Kakihara, S; Nakamura, J; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R	1
Al Chekakie, MO; Ketz, JM; Whinney, CM	1
Harada, M; Kubo, H; Ohmori, T; Sumitani, S	1
Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G	1
Murphy, D; Yui, K	1
Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ	1
Cohen, LJ; Galynker, II; Prosser, JM; Steele, A; Yard, S	1
Daliahu, Y; Melamed, Y; Paleacu, D	1
LeBlanc, SR; Ovanessian, MM; Parikh, SV	1
Calabrese, JR; Cao, L; Chen, J; Cui, X; Fang, Y; Gao, K; Hong, W; Jiang, K; Wang, Y; Wu, Z; Xu, Y; Yi, Z; Yuan, C	1
Gurwitz, D; Morag, A; Oved, K	1
Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C	1
Garabadu, D; Joy, KP; Krishnamurthy, S	1
Ahmad, A; Garabadu, D; Krishnamurthy, S	1
Ago, Y; Hasebe, S; Hashimoto, H; Matsuda, T; Nishiyama, S; Oka, S; Takuma, K	1
Baroni, M; Boccardi, V; Ercolani, S; Giordano, M; Longo, A; Mecocci, P; Paolacci, L; Ruggiero, C	1
Abbara, C; Briet, M; Drevin, G; Jousset, N; Picard, N	1

Reviews

2 review(s) available for paroxetine and risperidone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[The treatment of OCD]. Ryoikibetsu shokogun shirizu, 2003, Issue:38 Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Drug Therapy, Combination; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors	2003

Trials

8 trial(s) available for paroxetine and risperidone

Article	Year
Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4 Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome	1999
Risperidone and paroxetine given singly and in combination for bipolar depression. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2004
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Schizophrenia	2005
Risperidone in the treatment of psychotic depression. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:4 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Time Factors	2006
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:6 Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2009
A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study. BMC psychiatry, 2009, May-26, Volume: 9 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outcome Assessment, Health Care; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Young Adult	2009
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5 Topics: Buspirone; China; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Remission Induction; Risperidone; Selective Serotonin Reuptake Inhibitors; Thyroid Hormones; Trazodone; Valproic Acid	2011
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. Journal of affective disorders, 2013, Sep-25, Volume: 150, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Remission Induction; Risperidone; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013

Other Studies

48 other study(ies) available for paroxetine and risperidone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physical binding pocket induction for affinity prediction. Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19 Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results	2011
Which metabolites circulate? Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5 Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations	2013
MICE models: superior to the HERG model in predicting Torsade de Pointes. Scientific reports, 2013, Volume: 3 Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:5 Topics: 1-Naphthylamine; Amoxicillin; Anti-Bacterial Agents; Antidepressive Agents; Cefotaxime; Corynebacterium; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Paroxetine; Risperidone; Serotonin Antagonists; Sertraline; Teicoplanin; Vancomycin	1996
Comment: delayed risperidone-induced neuroleptic malignant syndrome. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:11 Topics: Antimanic Agents; Drug Interactions; Humans; Lithium Chloride; Neuroleptic Malignant Syndrome; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	1996
Chronic schizophrenia: response to clozapine, risperidone, and paroxetine. The American journal of psychiatry, 1997, Volume: 154, Issue:4 Topics: Chronic Disease; Clozapine; Drug Therapy, Combination; Humans; Middle Aged; Paroxetine; Risperidone; Schizophrenia	1997
Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1 Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	1998
Rapid onset tardive dyskinesia ("fly catcher tongue") in a neuroleptically naive patient induced by risperidone. Medicine and health, Rhode Island, 1998, Volume: 81, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Mastication; Paranoid Disorders; Paroxetine; Risperidone; Tongue	1998
Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:1 Topics: Adult; Comorbidity; Dopamine Antagonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Treatment of vocally disruptive behaviour of multifactorial aetiology. International journal of geriatric psychiatry, 1999, Volume: 14, Issue:4 Topics: Aged; Akathisia, Drug-Induced; Behavior Therapy; Dementia; Depression; Female; Homes for the Aged; Humans; Mental Disorders; Noise; Nursing Homes; Paroxetine; Patient Compliance; Physical Therapy Modalities; Psychomotor Agitation; Restraint, Physical; Risperidone; Verbal Behavior	1999
Negative symptoms due to sleep apnea syndrome in a patient with a delusional disorder. European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Delusions; Haloperidol; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Severity of Illness Index; Sleep Apnea Syndromes	1999
Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection. Pharmacology, 2000, Volume: 60, Issue:1 Topics: Chromatography, High Pressure Liquid; Colorimetry; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Spectrophotometry, Ultraviolet	2000
Serotonin syndrome during treatment with paroxetine and risperidone. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:1 Topics: Affective Disorders, Psychotic; Humans; Male; Middle Aged; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome	2000
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain. Neuroscience letters, 2000, Jun-23, Volume: 287, Issue:2 Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Carrier Proteins; Caudate Nucleus; Cocaine; Dibenzothiazepines; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nucleus Accumbens; Olanzapine; Paroxetine; Pirenzepine; Prosencephalon; Putamen; Quetiapine Fumarate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tritium	2000
Drug induced akathisia, suicidal ideation and its treatment in the elderly. International journal of geriatric psychiatry, 2001, Volume: 16, Issue:2 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors	2001
Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine. Therapeutic drug monitoring, 2001, Volume: 23, Issue:3 Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Selective Serotonin Reuptake Inhibitors	2001
Comments on "Serotonin syndrome during treatment with paroxetine and risperidone". Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:3 Topics: Humans; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome	2001
[Paroxetine augmentation with risperidone in therapy-resistant depression]. Psychiatrische Praxis, 2001, Volume: 28, Issue:8 Topics: Aged; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Paroxetine; Recurrence; Risperidone; Treatment Outcome	2001
Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Irish medical journal, 2002, Volume: 95, Issue:1 Topics: Adrenal Cortex Hormones; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Churg-Strauss Syndrome; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Paroxetine; Risperidone; Venlafaxine Hydrochloride	2002
Occurrence of priapism with risperidone-paroxetine combination in an autistic child. Journal of child and adolescent psychopharmacology, 2004,Fall, Volume: 14, Issue:3 Topics: Adolescent; Autistic Disorder; Drug Therapy, Combination; Humans; Male; Paroxetine; Priapism; Risperidone	2004
Postpartum depression without delivering a child? Acta psychiatrica Scandinavica, 2005, Volume: 112, Issue:3 Topics: Alprazolam; Anti-Anxiety Agents; Depression, Postpartum; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Family; Female; Humans; Hysterectomy; Middle Aged; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Suicide, Attempted	2005
Hypothermia in a patient receiving risperidone and paroxetine. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dementia; Female; Humans; Hypothermia; Paroxetine; Risperidone	2006
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry research, 2007, Jan-15, Volume: 154, Issue:1 Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:1 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome	2008
[Cerebral physiopathology and treatment of Asperger disorder]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2008, Volume: 110, Issue:10 Topics: Adolescent; Adult; Asperger Syndrome; Brain; Child; Child, Preschool; Fatty Acids, Unsaturated; Female; Humans; Male; Paroxetine; Risperidone; Serotonin Antagonists	2008
Narcolepsy and psychotic states--a case report. The Israel journal of psychiatry and related sciences, 2009, Volume: 46, Issue:1 Topics: Antipsychotic Agents; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Comorbidity; Drug Therapy, Combination; Female; Hallucinations; Hospitalization; Humans; Modafinil; Narcolepsy; Paroxetine; Psychotic Disorders; Referral and Consultation; Risperidone; Selective Serotonin Reuptake Inhibitors; Sleep Paralysis; Young Adult	2009
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2010, Volume: 55, Issue:3 Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Combined Modality Therapy; Comorbidity; Database Management Systems; Humans; Inositol; Lamotrigine; Multicenter Studies as Topic; Paroxetine; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Recurrence; Research Design; Risperidone; Smoking; Substance-Related Disorders; Suicide; Treatment Outcome; Triazines; United States; Vitamin B Complex	2010
Sex differences in human lymphoblastoid cells sensitivities to antipsychotic drugs. Journal of molecular neuroscience : MN, 2013, Volume: 49, Issue:3 Topics: Anti-Inflammatory Agents; Antidepressive Agents; Antineoplastic Agents; Antipsychotic Agents; Cell Division; Cell Survival; Cells, Cultured; Cytostatic Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Dystonic Disorders; Female; Haloperidol; Humans; Lymphocytes; Male; Paroxetine; Risperidone; Schizophrenia; Sex Characteristics; Sex Distribution	2013
Risperidone ameliorates post-traumatic stress disorder-like symptoms in modified stress re-stress model. Neuropharmacology, 2013, Volume: 75 Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Immobility Response, Tonic; Male; Maze Learning; Paroxetine; Rats; Risperidone; Stress Disorders, Post-Traumatic; Swimming; Time Factors	2013
Risperidone Attenuates Modified Stress-Re-stress Paradigm-Induced Mitochondrial Dysfunction and Apoptosis in Rats Exhibiting Post-traumatic Stress Disorder-Like Symptoms. Journal of molecular neuroscience : MN, 2015, Volume: 56, Issue:2 Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Apoptosis; Brain; Corticosterone; Male; Maze Learning; Mitochondria; Paroxetine; Rats; Risperidone; Stress Disorders, Post-Traumatic	2015
Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice. Behavioural pharmacology, 2015, Volume: 26, Issue:7 Spec No Topics: Animals; Animals, Outbred Strains; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Desipramine; Duloxetine Hydrochloride; Fluvoxamine; Hydroxycorticosteroids; Idazoxan; Indoles; Male; Mice; Motor Activity; Neuropsychological Tests; Oxazines; Paroxetine; Piperazines; Psychotropic Drugs; Pyridines; Risperidone; Ritanserin; Social Behavior; Social Isolation; Sulfonamides; Venlafaxine Hydrochloride	2015
Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project. The journal of nutrition, health & aging, 2017, Volume: 21, Issue:4 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinergic Antagonists; Cognitive Dysfunction; Cross-Sectional Studies; Female; Hospitalization; Humans; Italy; Longitudinal Studies; Male; Memory; Outpatients; Paroxetine; Risperidone; Trazodone	2017
Pitfalls and challenges associated with phenoconversion in forensic toxcicology. Forensic science international. Genetics, 2021, Volume: 51 Topics: Adult; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Forensic Toxicology; Heterozygote; Humans; Male; Paroxetine; Pharmacogenetics; Phenotype; Risperidone; Serotonin Agents; Substance-Related Disorders; Venlafaxine Hydrochloride	2021